Bioinsecticides Market

Bioinsecticides Market Size & Growth (2022 - 2027)

Bioinsecticides Market was worth USD 4.3 Billion in 2021 and is expected to reach USD 6.5 Billion by 2026 with a CAGR of 19.29 %.

Bioinsecticides are biological agents used to kill pests that are harmful to plants. Every pest has its natural enemy which reduces its numbers. That includes bacteria, fungi, viruses, and insect parasitoids. For example Bacteria like Bacillus thuringenesis is effective against the cabbage looper which is caused by insect called Trichoplausiani. Some of the crop plants are modified through genetic engineering techniques by inserting cry genes of thuringenesis to develop resistance against the insects. So, the technological advancements in genetic engineering and manufacturing processes will strengthen the biological insecticides in the marketplace.

Bioinsecticides Market Drivers:

Rise in crop loss due to insects and diseases, development of pest-resistance to various chemicals, changing farming practices, and growing pest management industries are some of the major factors driving the market. However, some of the factors like the Stringent Regulations by EPA on pesticide use is slowing down growth of the market.

REPORT COVERAGE:

Market Segmentation:

Bioinsecticides Market - By Type:

• Predators

• Pathogens
• Parasites
• Natural insecticides

Bioinsecticides Market - By Crop Type:

• Cereals & Grains
• Oilseeds & Pulses
• Fruits & Vegetables
• Others

 Bioinsecticides Market - By Mode of Application:

• Soil treatment
• Seed treatment
• Foliar spray
• Post-harvest

Bioinsecticides Market - By Formulation and Mechanism:

• Dry
• Liquid

Geographical Analysis:

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

 North America has the largest share in the market owing to rise in eco-friendly farming practices in North America.

Key Players:

Major Players in the global Bioinsecticides market are Valent Biosciences Corporation, Syngenta AG, Bayer Crop Science AG, E. I. du Pont de Nemours and Company, Novozymes A/S, and Koppert B.V.